SALVESTRINI, VIOLA
SALVESTRINI, VIOLA
A critical review on oligometastatic disease: a radiation oncologist’s perspective
2022 Pacifico P.; Colciago R.R.; De Felice F.; Boldrini L.; Salvestrini V.; Nardone V.; Desideri I.; Greco C.; Arcangeli S.
Artificial Intelligence in radiotherapy: state of the art and future directions
2020 Francolini G.; Desideri I.; Stocchi G.; Salvestrini V.; Ciccone L.P.; Garlatti P.; Loi M.; Livi L.
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation
2022 Iori F.; Bruni A.; Cozzi S.; Ciammella P.; Di Pressa F.; Boldrini L.; Greco C.; Nardone V.; Salvestrini V.; Desideri I.; De Felice F.; Iotti C.
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial
2021 Livi L.; Barletta G.; Martella F.; Saieva C.; Desideri I.; Bacci C.; Del Bene M.R.; Airoldi M.; Amoroso D.; Coltelli L.; Scotti V.; Becherini C.; Visani L.; Salvestrini V.; Mariotti M.; Pedani F.; Bernini M.; Sanchez L.; Orzalesi L.; Nori J.; Bianchi S.; Olivotto I.; Meattini I.
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?
2019 Bonomo P.; Greto D.; Desideri I.; Loi M.; Di Cataldo V.; Orlandi E.; Iacovelli N.A.; Becherini C.; Visani L.; Salvestrini V.; Mariotti M.; Livi L.
Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility (Supportive Care in Cancer, (2021), 29, 6, (2931-2937), 10.1007/s00520-020-05793-3)
2022 Desideri I.; Francolini G.; Ciccone L.P.; Stocchi G.; Salvestrini V.; Aquilano M.; Greto D.; Bonomo P.; Meattini I.; Scotti V.; Scoccianti S.; Simontacchi G.; Livi L.
Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial
2022 Bonomo P.; Desideri I.; Mangoni M.; Saieva C.; Loi M.; Becherini C.; Cerbai C.; Ganovelli M.; Salvestrini V.; Stocchi G.; Zani M.; Palomba A.; Livi L.
ESTRO vision 2030: the young Italian Association of Radiotherapy and Clinical Oncology (yAIRO) commitment statement
2021 De Felice F.; Boldrini L.; Greco C.; Nardone V.; Salvestrini V.; Desideri I.
Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study
2020 Meattini, Icro; Poortmans, Philip; Kirova, Youlia; Saieva, Calogero; Visani, Luca; Salvestrini, Viola; Kim, Jiyoung; Jung, Wonguen; Olmetto, Emanuela; Mariotti, Matteo; Desideri, Isacco; Fourquet, Alain; Livi, Lorenzo; Kim, Kyubo
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility
2020 Desideri I.; Francolini G.; Ciccone L.P.; Stocchi G.; Salvestrini V.; Aquilano M.; Greto D.; Bonomo P.; Meattini I.; Scotti V.; Scoccianti S.; Simontacchi G.; Livi L.
Impact of COVID-19 on workload burden of a complex radiotherapy facility
2021 Francolini G.; Desideri I.; Stocchi G.; Ciccone L.P.; Salvestrini V.; Garlatti P.; Aquilano M.; Greto D.; Bonomo P.; Meattini I.; Scotti V.; Scoccianti S.; Simontacchi G.; Livi L.
Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population
2021 Salvestrini V.; Mariotti M.; Banini M.; Becherini C.; Visani L.; Scotti V.; Desideri I.; Livi L.; Meattini I.
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases
2020 Desideri I.; Becherini C.; Visani L.; Stocchi G.; Scoccimarro E.; Mariotti M.; Salvestrini V.; Scoccianti S.; Greto D.; Bonomo P.; Pecchioli G.; Bordi L.; Della Puppa A.; Francolini G.; Meattini I.; Livi L.
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis
2022 Francolini G.; Bellini C.; Di Cataldo V.; Detti B.; Bruni A.; Alicino G.; Triggiani L.; La Mattina S.; D'Angelillo R.M.; Demofonti C.; Mazzola R.; Cuccia F.; Alongi F.; Aquilano M.; Allegra A.G.; Ciccone L.P.; Burchini L.; Salvestrini V.; Morelli I.; Frosini G.; Desideri I.; Livi L.
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial
2019 Livi, Lorenzo; Scotti, Vieri; Desideri, Isacco; Saieva, Calogero; Cecchini, Sara; Francolini, Giulio; Becherini, Carlotta; Delli Paoli, Camilla; Visani, Luca; Salvestrini, Viola; De Feo, Maria Laura; Nori, Jacopo; Bernini, Marco; Sanchez, Luis; Orzalesi, Lorenzo; Bianchi, Simonetta; Meattini, Icro
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy
2021 Bernini M.; Meattini I.; Saieva C.; Becherini C.; Salvestrini V.; Visani L.; Stocchi G.; Bellini C.; Lorenzetti V.; Sordi S.; Nori J.; De Benedetto D.; Desideri I.; Bianchi S.; Livi L.; Orzalesi L.
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy
2022 Francolini, Giulio; Frosini, Giulio; Di Cataldo, Vanessa; Detti, Beatrice; Carnevale, Maria Grazia; Banini, Marco; Peruzzi, Anna; Salvestrini, Viola; Visani, Luca; Olmetto, Emanuela; Becherini, Carlotta; Allegra, Andrea; Burchini, Luca; Scotti, Vieri; Mangoni, Monica; Meattini, Icro; Desideri, Isacco; Livi, Lorenzo
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)
2022 Meattini I.; Francolini G.; Di Cataldo V.; Visani L.; Becherini C.; Scoccimarro E.; Salvestrini V.; Bellini C.; Masi L.; Doro R.; Di Naro F.; Loi M.; Salvatore G.; Simontacchi G.; Greto D.; Bernini M.; Nori J.; Orzalesi L.; Bianchi S.; Mangoni M.; Livi L.
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275)
2022 Giulio Francolini, Mauro Loi, Lucia Pia Ciccone, Beatrice Detti, Vanessa Di Cataldo, Pamela Pinzani, Francesca Salvianti, Giulia Salvatore, Mariangela Sottili, Costanza Santini, Giulio Frosini, Luca Visani, Luca Burchini, Chiara Mattioli, Andrea Gaetano Allegra, Marianna Valzano, Cecilia Cerbai, Michele Aquilano, Viola Salvestrini, Isacco Desideri, Monica Mangoni, Icro Meattini, Lorenzo Livi
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275)
2021 Francolini G.; Loi M.; Salvestrini V.; Mangoni M.; Detti B.; Di Cataldo V.; Aquilano M.; Pinzani P.; Salvianti F.; Desideri I.; Mariotti M.; Garlatti P.; Stocchi G.; Ciccone L.P.; Lucidi S.; Salvatore G.; Sottili M.; Meattini I.; Livi L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A critical review on oligometastatic disease: a radiation oncologist’s perspective | 2022 | Pacifico P.; Colciago R.R.; De Felice F.; Boldrini L.; Salvestrini V.; Nardone V.; Desideri I.; Greco C.; Arcangeli S. | |
| Artificial Intelligence in radiotherapy: state of the art and future directions | 2020 | Francolini G.; Desideri I.; Stocchi G.; Salvestrini V.; Ciccone L.P.; Garlatti P.; Loi M.; Livi L. | |
| Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation | 2022 | Iori F.; Bruni A.; Cozzi S.; Ciammella P.; Di Pressa F.; Boldrini L.; Greco C.; Nardone V.; Salvestrini V.; Desideri I.; De Felice F.; Iotti C. | |
| Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial | 2021 | Livi L.; Barletta G.; Martella F.; Saieva C.; Desideri I.; Bacci C.; Del Bene M.R.; Airoldi M.; Amoroso D.; Coltelli L.; Scotti V.; Becherini C.; Visani L.; Salvestrini V.; Mariotti M.; Pedani F.; Bernini M.; Sanchez L.; Orzalesi L.; Nori J.; Bianchi S.; Olivotto I.; Meattini I. | |
| Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? | 2019 | Bonomo P.; Greto D.; Desideri I.; Loi M.; Di Cataldo V.; Orlandi E.; Iacovelli N.A.; Becherini C.; Visani L.; Salvestrini V.; Mariotti M.; Livi L. | |
| Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility (Supportive Care in Cancer, (2021), 29, 6, (2931-2937), 10.1007/s00520-020-05793-3) | 2022 | Desideri I.; Francolini G.; Ciccone L.P.; Stocchi G.; Salvestrini V.; Aquilano M.; Greto D.; Bonomo P.; Meattini I.; Scotti V.; Scoccianti S.; Simontacchi G.; Livi L. | |
| Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial | 2022 | Bonomo P.; Desideri I.; Mangoni M.; Saieva C.; Loi M.; Becherini C.; Cerbai C.; Ganovelli M.; Salvestrini V.; Stocchi G.; Zani M.; Palomba A.; Livi L. | |
| ESTRO vision 2030: the young Italian Association of Radiotherapy and Clinical Oncology (yAIRO) commitment statement | 2021 | De Felice F.; Boldrini L.; Greco C.; Nardone V.; Salvestrini V.; Desideri I. | |
| Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study | 2020 | Meattini, Icro; Poortmans, Philip; Kirova, Youlia; Saieva, Calogero; Visani, Luca; Salvestrini, Viola; Kim, Jiyoung; Jung, Wonguen; Olmetto, Emanuela; Mariotti, Matteo; Desideri, Isacco; Fourquet, Alain; Livi, Lorenzo; Kim, Kyubo | |
| Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility | 2020 | Desideri I.; Francolini G.; Ciccone L.P.; Stocchi G.; Salvestrini V.; Aquilano M.; Greto D.; Bonomo P.; Meattini I.; Scotti V.; Scoccianti S.; Simontacchi G.; Livi L. | |
| Impact of COVID-19 on workload burden of a complex radiotherapy facility | 2021 | Francolini G.; Desideri I.; Stocchi G.; Ciccone L.P.; Salvestrini V.; Garlatti P.; Aquilano M.; Greto D.; Bonomo P.; Meattini I.; Scotti V.; Scoccianti S.; Simontacchi G.; Livi L. | |
| Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population | 2021 | Salvestrini V.; Mariotti M.; Banini M.; Becherini C.; Visani L.; Scotti V.; Desideri I.; Livi L.; Meattini I. | |
| Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases | 2020 | Desideri I.; Becherini C.; Visani L.; Stocchi G.; Scoccimarro E.; Mariotti M.; Salvestrini V.; Scoccianti S.; Greto D.; Bonomo P.; Pecchioli G.; Bordi L.; Della Puppa A.; Francolini G.; Meattini I.; Livi L. | |
| Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis | 2022 | Francolini G.; Bellini C.; Di Cataldo V.; Detti B.; Bruni A.; Alicino G.; Triggiani L.; La Mattina S.; D'Angelillo R.M.; Demofonti C.; Mazzola R.; Cuccia F.; Alongi F.; Aquilano M.; Allegra A.G.; Ciccone L.P.; Burchini L.; Salvestrini V.; Morelli I.; Frosini G.; Desideri I.; Livi L. | |
| Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial | 2019 | Livi, Lorenzo; Scotti, Vieri; Desideri, Isacco; Saieva, Calogero; Cecchini, Sara; Francolini, Giulio; Becherini, Carlotta; Delli Paoli, Camilla; Visani, Luca; Salvestrini, Viola; De Feo, Maria Laura; Nori, Jacopo; Bernini, Marco; Sanchez, Luis; Orzalesi, Lorenzo; Bianchi, Simonetta; Meattini, Icro | |
| Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy | 2021 | Bernini M.; Meattini I.; Saieva C.; Becherini C.; Salvestrini V.; Visani L.; Stocchi G.; Bellini C.; Lorenzetti V.; Sordi S.; Nori J.; De Benedetto D.; Desideri I.; Bianchi S.; Livi L.; Orzalesi L. | |
| Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy | 2022 | Francolini, Giulio; Frosini, Giulio; Di Cataldo, Vanessa; Detti, Beatrice; Carnevale, Maria Grazia; Banini, Marco; Peruzzi, Anna; Salvestrini, Viola; Visani, Luca; Olmetto, Emanuela; Becherini, Carlotta; Allegra, Andrea; Burchini, Luca; Scotti, Vieri; Mangoni, Monica; Meattini, Icro; Desideri, Isacco; Livi, Lorenzo | |
| Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) | 2022 | Meattini I.; Francolini G.; Di Cataldo V.; Visani L.; Becherini C.; Scoccimarro E.; Salvestrini V.; Bellini C.; Masi L.; Doro R.; Di Naro F.; Loi M.; Salvatore G.; Simontacchi G.; Greto D.; Bernini M.; Nori J.; Orzalesi L.; Bianchi S.; Mangoni M.; Livi L. | |
| Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) | 2022 | Giulio Francolini, Mauro Loi, Lucia Pia Ciccone, Beatrice Detti, Vanessa Di Cataldo, Pamela Pinzani, Francesca Salvianti, Giulia Salvatore, Mariangela Sottili, Costanza Santini, Giulio Frosini, Luca Visani, Luca Burchini, Chiara Mattioli, Andrea Gaetano Allegra, Marianna Valzano, Cecilia Cerbai, Michele Aquilano, Viola Salvestrini, Isacco Desideri, Monica Mangoni, Icro Meattini, Lorenzo Livi | |
| Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) | 2021 | Francolini G.; Loi M.; Salvestrini V.; Mangoni M.; Detti B.; Di Cataldo V.; Aquilano M.; Pinzani P.; Salvianti F.; Desideri I.; Mariotti M.; Garlatti P.; Stocchi G.; Ciccone L.P.; Lucidi S.; Salvatore G.; Sottili M.; Meattini I.; Livi L. |